Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris

Journal of the American Academy of Dermatology

Volumn 49, Issue 6, 2003, Pages 1059-1062

  Mimouni, Daniel ^a,b,c   Nousari, Carlos H ^a   Cummins, Deborah L ^a   Kouba, David J ^a   David, Michael ^a,b,c   Anhalt, Grant J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADJUVANT THERAPY; ARTICLE; DIAGNOSTIC APPROACH ROUTE; DRUG DOSE REGIMEN; HEALTH SURVEY; HUMAN; IMMUNOFLUORESCENCE; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT REFERRAL; PEMPHIGUS VULGARIS; PHYSICIAN; PRIORITY JOURNAL; SKIN BIOPSY; TELEPHONE; TISSUE SECTION; TREATMENT PLANNING;

EID: 0345724922     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02738-5     Document Type: Article

References (5)

1. Tuohy VK, Kinkel RP. Epitope spreading: a mechanism for progression of autoimmune disease. Arch Immunol Ther Exp (Warsz) 2000;48:347-51.
2. Stanley JR. Pemphigus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz ST, et al, editors. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 1999. p. 654-66.
3. Mimouni D, Anhalt GJ. Pemphigus. Dermatol Ther 2002;15:362-8.
4. Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 1997;350:494.
5. Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Treatment of pemphigus vulgaris and foliaceus with mycophenolate mofetil. Arch Dermatol 2003;139:739-42.